Parkway Life Real Estate Investment Trust
Parkway Life Real Estate Investment Trust
Your view on PRKWF
Overview
What the company does, where it operates, and who runs it.
About Parkway Life Real Estate Investment Trust
- Industry
- REIT - Healthcare Facilities
- Sector
- Real Estate
- CEO
- Yean Chau Yong
- Headquarters
- 80 Robinson Road, No. 02-00, Singapore, SG
- Industry
- REIT - Healthcare Facilities
- Sector
- Real Estate
- CEO
- Yean Chau Yong
- Headquarters
- 80 Robinson Road, No. 02-00, Singapore, SG
Parkway Life Real Estate Investment Trust ("PLife REIT") is one of Asia's largest listed healthcare REITs by asset size.
It invests in income-producing real estate and real estate related assets that are used primarily for healthcare and healthcare-related purposes (including but are not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices).
PLife REIT owns a well-diversified portfolio of 54 properties located in the Asia Pacific region, with a total portfolio size of approximately S$2.02 billion3 as at 31 December 2020.
It owns the largest portfolio of strategically-located private hospitals in Singapore comprising Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital. In addition, it has 50 assets of high quality nursing home and care facility properties in various prefectures of Japan.
It also owns strata-titled units/lots in MOB Specialist Clinics Kuala Lumpur in Malaysia.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Parkway Life Real Estate Investment Trust, and the rating behind it. PRKWF last traded at $3.13, 15.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Parkway Life Real Estate Investment Trust. Starting points for Parkway Life Real Estate Investment Trust: P/E 15.6, EPS $0.25, beta 0.41 — an REIT - Healthcare Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Parkway Life Real Estate Investment Trust. Parkway Life Real Estate Investment Trust does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Parkway Life Real Estate Investment Trust. Trailing twelve-month EPS for Parkway Life Real Estate Investment Trust stands at $0.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Parkway Life Real Estate Investment Trust. Parkway Life Real Estate Investment Trust has reported as a listed company since 2011. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Parkway Life Real Estate Investment Trust valued side by side against its closest peers. Parkway Life Real Estate Investment Trust is measured against REIT - Healthcare Facilities peers within the Real Estate sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Parkway Life Real Estate Investment Trust, and how their positions are changing. At a $2.04B market value, institutional positions materially move Parkway Life Real Estate Investment Trust's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Parkway Life Real Estate Investment Trust executives and directors. Shares of Parkway Life Real Estate Investment Trust have traded between $2.65 and $3.37 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Parkway Life Real Estate Investment Trust. Parkway Life Real Estate Investment Trust is a $2.04B Real Estate company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Parkway Life Real Estate Investment Trust. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Parkway Life Real Estate Investment Trust. Coverage tracks Parkway Life Real Estate Investment Trust within REIT - Healthcare Facilities (Real Estate). Press releases and market coverage, newest first.